Homozygous familial hypercholesterolaemia in childhood – The first case report in Southeast Europe. (December 2019)

• Record Type: Journal Article
• Authors: Bjelakovic, Bojko; Stefanutti, Claudia; Pisciotta, Livia; Watts, Gerald; Bejiqi, Ramush
• Is Part Of: Atherosclerosis. Volume 40(2019)
• Page Start: 122
• Page End: 124
• Publication Date: 2019-12
• Subjects: Homozygous familial hypercholesterolemia -- Southeastern europe -- Healthcare access -- Children -- Therapeutic plasmapheresis; Atherosclerosis -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; Periodicals; 616.136
• DOI: 10.1016/j.atherosclerosissup.2019.08.034
• Languages: English
• ISSNs: 1567-5688

Abstract

Abstract: Homozygous familial hypercholesterolaemia (HoFH) is the rare, severe, but treatable disease characterised by exceedingly high levels of low-density lipoprotein cholesterol (LDL-C) and subsequent premature coronary heart disease. Of note, HoFH detection rate and patient access to healthcare and treatment modalities still differ considerably across EU countries. To our current knowledge, there are still no published reports describing HoFH in the paediatric population of Southeastern Europe. In this case report, a few important topics on obstacles in getting adequate health care service and management of HoFH children from Southeastern Europe are tackled.